Curable composition comprising a thermolatent base

US8969577B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8969577-B2
Application numberUS-200913130331-A
CountryUS
Kind codeB2
Filing dateNov 18, 2009
Priority dateNov 24, 2008
Publication dateMar 3, 2015
Grant dateMar 3, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to curable compositions comprising a thermolatent amidine base and an organic material which is polymerizable or crosslinkable with a basic or nucleophilic catalyst. In particular, the invention relates to curable coating compositions, especially powder coating compositions, and curable adhesive compositions, as well as to the use a thermolatent amidine base as a curing catalyst for thermally induced base-catalyzed polymerization or crosslinking reactions.

First claim

Opening claim text (preview).

The invention claimed is: 1. A curable composition comprising (A) an organic material which is polymerisable or crosslinkable with a basic or nucleophilic catalyst, (B) a compound of the formula wherein R 1 forms together with the carbon and nitrogen atom, it is linked to, a mono- or polycyclic C 2 -C 20 ring system selected from the group consisting of imidazole, benzimidazole, thiazole, benzothiazole, pyrazole, oxazole, benzoxazole, isoxazole, isothiazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, 1,2,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-oxadiazole, 1,3,4-thiadiazole, pyridine, quinoline, isoquinoline, phenanthridine, pyridazine, pyrimidine, pyrazine, cinnoline, phthalazine, chinazoline, chinoxaline, chinazolinone, 1,3,5-triazine, 1,2,4,5-tetrazine, purine, xanthine, hypoxanthine, guanine, adenine, pteridine, pterine, 1,10-phenanthroline, 2,2′-bipyridine, 4,4′-bipyridine, said ring system is unsubstituted or substituted by C 1 -C 8 alkyl; C 5 -C 7 cycloalkyl; C 6 -C 12 aryl; C 6 -C 18 aryl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; C 1 -C 8 alkoxy; C 1 -C 8 alkoxy, which is substituted by E and/or interrupted by D; C 7 -C 11 aralkyl; C 7 -C 11 aralkyl, which is substituted by G; halogen, OH, oxo, CN, NH 2 , NHR 6 , NR 7 R 8 , CONH 2 , CONR 9 R 10 , COR 11 , C(O)OR 12 , wherein R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are independently of each other C 1 -C 8 alkyl; C 1 -C 8 alkyl, which is interrupted by —O—; C 6 -C 12 aryl; C 6 -C 12 aryl, which is substituted by C 1 -C 8 alkyl or C 1 -C 8 alkoxy; C 7 -C 11 aralkyl; C 7 -C 11 aralkyl, which is substituted by G; or R 7 and R 8 form an organic bridging group completing, together with the nitrogen atom, they are linked to, a heterocyclic ring of 5 to 7 ring atoms in total; or said ring system is further anellated by one or more benzene rings R 2 , R 3 , R 4 and R 5 are independently of each other H; C 1 -C 18 alkyl; C 1 -C 18 alkyl, which is substituted by E and/or interrupted by D; C 5 -C 12 cycloalkyl; C 5 -C 12 cycloalkyl, which is substituted by E; C 6 -C 12 aryl; C 6 -C 18 aryl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; C 1 -C 18 alkoxy; C 1 -C 18 alkoxy, which is substituted by E and/or interrupted by D; C 7 -C 18 aralkyl; C 7 -C 18 aralkyl, which is substituted by G; NHR 18 , NR 19 R 20 , COOH; or R 2 and R 3 , R 4 and R 5 , or R 2 and R 4 form an organic bridging group completing, together with the carbon atom, they are linked to, a carbocyclic or heterocyclic ring of 5 to 12 ring atoms in total; or two of R 5 , which are linked to adjacent carbon atoms, form an organic bridging group completing, together with the carbon atom, they are linked to, a carbocyclic or heterocyclic ring of 5 to 12 ring atoms in total; D is —CO—; —COO—; —S—; —SO—; —SO 2 —; —O—; —NR 21 —; —SiR 22 R 23 —; —POR 24 —; —CR 25 ═CR 26 —; or —C≡C—; E is OR 27 ; SR 28 ; SOR 29 ; SO 2 R 30 ; NR 31 R 32 ; COR 33 ; COOR 34 ; CONR 35 R 36 ; PO(R 37 ) 2 ; CN; or halogen; and G is E or C 1 -C 18 alkyl; R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , R 27 , R 28 , R 29 , R 30 , R 31 , R 32 , R 33 , R 34 , R 35 , R 36 and R 37 are independently of each other C 1 -C 18 alkyl; C 1 -C 18 alkyl, which is interrupted by —O—; C 6 -C 18 aryl; C 6 -C 18 aryl, which is substituted by C 1 -C 18 alkyl or C 1 -C 18 alkoxy; C 7 -C 18 aralkyl; C 7 -C 18 aralkyl, which is substituted by G; C 2 -C 18 heteroaryl; or R 19 and R 20 , R 31 and R 32 , or R 35 and R 36 form an organic bridging group completing, together with the nitrogen atom, they are linked to, a heterocyclic ring of 5 to 7 ring atoms in total; L is a n-valent leaving group, n is an integer of 1, 2, 3 or 4; p is an integer of 1, 2, 3 or 4, (C) a curing catalyst other than component (B) and (D) at least one additive if n is 1, L is halogen, OH, OR 40 , SR 40 , OCOR 40 , OCOOR 41 , OCONR 42 R 43 , OCSNR 42 R 43 , OSO 2 R 40 , OSO 3 R 40 , NR 42 R 43 , S + R 42 R 43 X − , N + R 42 R 43 R 44 X − , P + R 42 R 43 X − , NHCOR 40 , OPO(OR 40 ) 2 , OPO(R 46 )(OR 47 ), OSi(R 40 ) 3 ; wherein R 40 , R 42 , R 43 , R 44 , R 45 , R 46 and R 47 are independently of each other H, C 1 -C 18 alkyl or C 1 -C 18 alkyl, which is substituted by E and/or interrupted by D; C 5 -C 12 cycloalkyl, C 5 -C 12 cycloalkyl, which is substituted by E and/or interrupted by D; C 6 -C 18 aryl; C 6 -C 18 aryl, which is substituted by G; C 7 -C 18 aralkyl; C 7 -C 18 aralkyl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; or R 42 and R 43 form an organic bridging group completing, together with the nitrogen atom, they are linked to, a heterocyclic ring of 5 to 7 ring atoms in total; or two of R 45 form a bridging group completing, together with the —OC—N—CO-group, they are linked to, a heterocyclic ring of 5 to 7 ring atoms in total; R 41 is C 1 -C 18 alkyl or C 1 -C 18 alkyl, which is substituted by E and/or interrupted by D; C 5 -C 12 cycloalkyl, C 5 -C 12 cycloalkyl, which is substituted by E and/or interrupted by D; C 6 -C 18 aryl; C 1 -C 18 aryl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; X − is halide, hydroxide, C 1 -C 18 alkylsulfonate, C 6 -C 18 arylsulfonate, R 48 COO − , HSO 4 − or ½ SO 4 2− , wherein R 48 is H, C 1 -C 18 alkyl or C 1 -C 18 alkyl, which is substituted by E and/or interrupted by D; C 5 -C 12 cycloalkyl, C 5 -C 12 cycloalkyl, which is substituted by E and/or interrupted by D; C 6 -C 18 aryl; C 6 -C 18 aryl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; if n is 2, L is —OCO—O—, —OSO 2 O—, —OCO—(CH 2 ) q —COO—, —OSi(CH 3 ) 2 O—, —OCON(CH 2 ) q , wherein q is 0 or an integer of 1 to 10; or if n is 3 or 4, L is 2. A composition according to claim 1 , wherein R 2 , R 3 , R 4 and R 5 are independently of each other H; C 1 -C 8 alkyl; C 5 -C 8 cycloalkyl; C 6 -C 18 aryl; C 6 -C 18 aryl, which is substituted by G; C 2 -C 18 heteroaryl; C 2 -C 18 heteroaryl, which is substituted by G; C 1 -C 4 alkoxy; C 7 -C 10 aralkyl; NHR 6 , NR 7 R 8 , wherein R 6 , R 7 and R 8 are independently of each other C 1 -C 4 alkyl; C 6 -C 12 aryl; C 6 -C 12 aryl, which is substituted by C 1 -C 4 alkyl or C 1 -C 4 alkoxy; C 7 -C 10 aralkyl; or R 7 and R 8 form an organic bridging group completing, together with the nitrogen atom, they are linked to, a heterocyclic ring of 5 to 7 ring atoms in total; or R 2 and R 3 , R 4 and R 5 , or R 2 and R 4 form an organic bridging group completing, together with the carbon atom, they are linked to, a carbocyclic or heterocyclic ring of 5 to 7 ring atoms in total; or two of R 5 , which are linked to adjacent carbon atoms, form an organic bridging group completing, together with the carbon atom, they are linked to, a carbocyclic or heterocyclic ring of 5 to 7 ring atoms in total. 3. A composition according to claim 1 , wherein R 2 , R 3 , R 4 and R 5 are independently of each other H or C 1 -C 4 alkyl, and p is an integer of 1 or 2. 4. A composition according to claim 1

Assignees

Inventors

Classifications

  • Nitrogen atoms (nitro radicals C07D215/18) · CPC title

  • containing nitrogen · CPC title

  • C07D213/74Primary

    Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title

  • Compositions of epoxy resins; Compositions of derivatives of epoxy resins · CPC title

  • polymers with carboxylic terminal groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8969577B2 cover?
The present invention relates to curable compositions comprising a thermolatent amidine base and an organic material which is polymerizable or crosslinkable with a basic or nucleophilic catalyst. In particular, the invention relates to curable coating compositions, especially powder coating compositions, and curable adhesive compositions, as well as to the use a thermolatent amidine base as a c…
Who is the assignee on this patent?
Nesvadba Peter, Folger Lucienne Bugnon, Knischka Ralf, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07D213/74. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).